Two people at a point-of-sale system. (Clay Banks/Unsplash)

ā€˜The pillā€™ will soon be available over the counter. The impacts could be sweeping

July 13, 2023

Federal regulators approved the first over-the-counter oral contraceptive. CU Boulderā€™s Amanda Stevenson says the impacts could be sweeping. But she cautions that real threats to contraceptive access in the U.S. still exist.

Woman works at large piece of scientific equipment

Weeks later, potentially harmful chemicals lingered in homes affected by Marshall Fire

July 6, 2023

In the wake of the devastating Marshall Fire, a team of chemists and engineers from CU Boulder undertook a first-of-its-kind study to explore homes that survived the blaze. Their results reveal the potential health hazards that wildfires can leave behind in buildings.

Maciej Walczak and his lab group

Chemist to study molecular inner workings of Alzheimerā€™s disease

July 6, 2023

Maciej Walczak, CU Boulder associate professor of chemistry, won a $2 million NIH grant to investigate how certain sugars modify a brain protein associated with neurodegeneration.

Breast tumor seen under a microscope

When it comes to treating resistant breast cancer, 2 drugs may be better than 1

June 15, 2023

New research shows that cancer cells can adapt in as little as one to two hours to new drugs called CDK2 inhibitors. The good news: Adding a second, widely available drug disables this workaround, squelching tumor growth.

The HIV virus, a retrovirus, under the microscope

Remnants of ancient virus may fuel ALS in people

June 6, 2023

An ancient, virus-like protein best known for its essential role in placental development may, when over-expressed, fuel ALSā€”aka Lou Gehrig's diseaseā€”and other neurodegenerative diseases, according to new research. The discovery opens the door to a new class of potential treatments.

Jennifer Doudna stands on stage at a podium

Forum on gene editing draws hundreds, some with tough questions

May 25, 2023

A revolutionary technique for editing genomes, called CRISPR-Cas9, has already helped cure sickle cell disease in dozens of people. But it also raises ethical concerns, which a panel of preeminent scientists grappled with at an event on the CU Boulder campus.

Cigarette burning

Does the sweet seduction of flavored tobacco make quitting harder?

May 4, 2023

A study led by a CU Boulder researcher finds that flavored tobacco products reduce the likelihood of cessation later, but researchers say more investigation is needed.

Cannabis

How cannabis may ease ā€˜chemo brainā€™ and improve sleep for cancer patients

April 27, 2023

A new study led by Angela Bryan, a CU Boulder professor and cancer survivor, is among the first to assess how cannabis bought over the counter at dispensariesā€”rather than government-supplied or synthetic varietiesā€”impacts cancer symptoms or chemotherapy side effects.

Pregnant belly with two sets of hands wrapped around it

ā€˜Obstetric racismā€™ prevalent in US, fueling rise in questionable labor inductions

April 26, 2023

The study of 46 million births across nearly three decades is among the first to provide population-level statistical evidence of ā€œobstetric racism,ā€ a term coined recently to describe a concerning pattern of maltreatment of non-white pregnant women, including a disregard for their birthing wishes.

Researcher holding the UV device used in the study

Study shows personal disinfection device safe for use in public spaces

April 19, 2023

Imagine carrying a UV device in your backpack and pulling it out to disinfect your bus seat or restaurant table. A new CU Boulder study shows that using a technology called Far UV-C kills almost 100% of pathogens within a few seconds, without risk to human bystanders.

Pages